Market Reports Center One Stop Market Research Shop
Gonorrhea Diagnostics Market Share, Size, Price, Growth, Trends and Forecast 2016 – 2020
Technavio Announces the Publication of its Research Report – Global Gonorrhea Diagnostics Market 2016-2020 Technavio recognizes the following companies as the key players in the global gonorrhea diagnostics market: Abbott Laboratories, Beckman Coulter, Roche Diagnostics, and Siemens. Other Prominent Vendors in the market are: Agilent Technologies, Alere, Becton Dickinson and Company, Bio-Rad, Cepheid, Diamedix, Kyowa Medex, Lonza, Mackay Life Sciences, Nihon Kohden, Ortho-Clinical Diagnostics, Polymedco, Qiagen, SDIX, Sequenom, Sienco, Sysmex, Takara Bio, and Thermo Fisher. Commenting on the report, an analyst from Technavio’ s team said: “A trend which is already contributing to market growth is the growing use of molecular diagnostics. Molecular diagnostics are used to study the chemical structure of DNA to determine the presence of an abnormal gene sequences, which could be the potential cause for the disease caused by an organism or pathogen. Therefore, physicians can isolate the specific gene polymorphisms causing the disease directly, or indirectly target DNA through amplification based on the amount of target DNA present. Molecular diagnostics represent the first step toward understanding a disease at the molecular level and is the fastest-growing clinical diagnostics technology.” Download Brochure now @ https://marketreportscenter.com/reports/313720/global-gonorrheadiagnostics-market-2016-2020 According to the report, a key growth driver is the rising number of gonorrhea cases. The incidence of gonorrhea has been on the rise worldwide. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. In 2014, as per the estimates by CDC, there were around 350,062 reported cases of gonorrhea (a rate of 110.7 per 100,000) in the US. The highest incidence of gonorrhea was observed in heterosexually infected men, especially those aged 25-34 years. During the last 10 years, women constituted only around 20%-30% of all the reported cases of gonorrhea.